Submaximal exercise testing may be superior to the 6-min walk test in assessing pulmonary arterial hypertension disease severity

Jennifer E. Neal, Augustine S. Lee, Charles Dwayne Burger

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Introduction: Submaximal exercise testing (SET) assesses functional exercise capacity in pulmonary arterial hypertension (PAH) patients and provides additional physiologic information compared with the 6-min walk test (6MWT). The relative correlations of the 6MWT and SET using SHAPE-HF™ with other markers of PAH severity, particularly echocardiogram (ECHO)-derived mean pulmonary artery pressure (MPAP), have not been investigated. Objectives: (i) Examine the correlation between SHAPE measures with the 6-min walk distance (6MWD), and (ii) Compare SHAPE parameters and the 6MWD to clinical measures of PAH severity. Methods: Fifty-five consecutive group 1 PAH outpatients were evaluated in a single pulmonary hypertension referral center from March 2011 to June 2012. Data collected: World Health Organization (WHO) functional class (FC), brain natriuretic peptide (BNP), ECHO, 6MWD and SHAPE results. Data are reported using mean±standard deviation and Spearman correlation coefficients (r). Results: Nine patients were excluded. Of the 46 remaining patients, 78% were women and the average age was 61±13 years. PAH characteristics: WHO FC III-IV 48%; idiopathic PAH 52%; BNP 198±277pg/mL; 6MWD 399±97m; ECHO right atrial pressure (RAP) 7±4, pulmonary artery systolic pressure (PASP) 63±29 and MPAP 45±17mmHg. SET with SHAPE results: mean partial pressure of end-tidal (PET) CO2 31±6mmHg at end-exercise; ventilatory efficiency (VE/VCO2) 43±16. Significant correlations were found between the 6MWD and SHAPE variables: VE/VCO2 (r=-0.57, P<0.0001) and end-exercise PETCO2 (r=0.42, P=0.004). VE/VCO2 correlated with WHO FC, BNP, RAP, MPAP and PASP and 6MWD only with WHO FC, BNP and PASP. Conclusion: SHAPE outperformed 6MWD in comparison with other measures of PAH disease severity.

Original languageEnglish (US)
Pages (from-to)404-409
Number of pages6
JournalClinical Respiratory Journal
Volume8
Issue number4
DOIs
StatePublished - Oct 1 2014

Fingerprint

Pulmonary Hypertension
Pulmonary Artery
Exercise
Brain Natriuretic Peptide
Atrial Pressure
Blood Pressure
Pressure
Partial Pressure
Walk Test
Outpatients
Referral and Consultation

Keywords

  • Cardiopulmonary exercise test
  • Echocardiography
  • Exercise test
  • Hypertension
  • Pulmonary

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Immunology and Allergy
  • Genetics(clinical)

Cite this

Submaximal exercise testing may be superior to the 6-min walk test in assessing pulmonary arterial hypertension disease severity. / Neal, Jennifer E.; Lee, Augustine S.; Burger, Charles Dwayne.

In: Clinical Respiratory Journal, Vol. 8, No. 4, 01.10.2014, p. 404-409.

Research output: Contribution to journalArticle

@article{5f36eb6d25a745e6bdf8c2d058ed23ff,
title = "Submaximal exercise testing may be superior to the 6-min walk test in assessing pulmonary arterial hypertension disease severity",
abstract = "Introduction: Submaximal exercise testing (SET) assesses functional exercise capacity in pulmonary arterial hypertension (PAH) patients and provides additional physiologic information compared with the 6-min walk test (6MWT). The relative correlations of the 6MWT and SET using SHAPE-HF™ with other markers of PAH severity, particularly echocardiogram (ECHO)-derived mean pulmonary artery pressure (MPAP), have not been investigated. Objectives: (i) Examine the correlation between SHAPE measures with the 6-min walk distance (6MWD), and (ii) Compare SHAPE parameters and the 6MWD to clinical measures of PAH severity. Methods: Fifty-five consecutive group 1 PAH outpatients were evaluated in a single pulmonary hypertension referral center from March 2011 to June 2012. Data collected: World Health Organization (WHO) functional class (FC), brain natriuretic peptide (BNP), ECHO, 6MWD and SHAPE results. Data are reported using mean±standard deviation and Spearman correlation coefficients (r). Results: Nine patients were excluded. Of the 46 remaining patients, 78{\%} were women and the average age was 61±13 years. PAH characteristics: WHO FC III-IV 48{\%}; idiopathic PAH 52{\%}; BNP 198±277pg/mL; 6MWD 399±97m; ECHO right atrial pressure (RAP) 7±4, pulmonary artery systolic pressure (PASP) 63±29 and MPAP 45±17mmHg. SET with SHAPE results: mean partial pressure of end-tidal (PET) CO2 31±6mmHg at end-exercise; ventilatory efficiency (VE/VCO2) 43±16. Significant correlations were found between the 6MWD and SHAPE variables: VE/VCO2 (r=-0.57, P<0.0001) and end-exercise PETCO2 (r=0.42, P=0.004). VE/VCO2 correlated with WHO FC, BNP, RAP, MPAP and PASP and 6MWD only with WHO FC, BNP and PASP. Conclusion: SHAPE outperformed 6MWD in comparison with other measures of PAH disease severity.",
keywords = "Cardiopulmonary exercise test, Echocardiography, Exercise test, Hypertension, Pulmonary",
author = "Neal, {Jennifer E.} and Lee, {Augustine S.} and Burger, {Charles Dwayne}",
year = "2014",
month = "10",
day = "1",
doi = "10.1111/crj.12085",
language = "English (US)",
volume = "8",
pages = "404--409",
journal = "Clinical Respiratory Journal",
issn = "1752-6981",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Submaximal exercise testing may be superior to the 6-min walk test in assessing pulmonary arterial hypertension disease severity

AU - Neal, Jennifer E.

AU - Lee, Augustine S.

AU - Burger, Charles Dwayne

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Introduction: Submaximal exercise testing (SET) assesses functional exercise capacity in pulmonary arterial hypertension (PAH) patients and provides additional physiologic information compared with the 6-min walk test (6MWT). The relative correlations of the 6MWT and SET using SHAPE-HF™ with other markers of PAH severity, particularly echocardiogram (ECHO)-derived mean pulmonary artery pressure (MPAP), have not been investigated. Objectives: (i) Examine the correlation between SHAPE measures with the 6-min walk distance (6MWD), and (ii) Compare SHAPE parameters and the 6MWD to clinical measures of PAH severity. Methods: Fifty-five consecutive group 1 PAH outpatients were evaluated in a single pulmonary hypertension referral center from March 2011 to June 2012. Data collected: World Health Organization (WHO) functional class (FC), brain natriuretic peptide (BNP), ECHO, 6MWD and SHAPE results. Data are reported using mean±standard deviation and Spearman correlation coefficients (r). Results: Nine patients were excluded. Of the 46 remaining patients, 78% were women and the average age was 61±13 years. PAH characteristics: WHO FC III-IV 48%; idiopathic PAH 52%; BNP 198±277pg/mL; 6MWD 399±97m; ECHO right atrial pressure (RAP) 7±4, pulmonary artery systolic pressure (PASP) 63±29 and MPAP 45±17mmHg. SET with SHAPE results: mean partial pressure of end-tidal (PET) CO2 31±6mmHg at end-exercise; ventilatory efficiency (VE/VCO2) 43±16. Significant correlations were found between the 6MWD and SHAPE variables: VE/VCO2 (r=-0.57, P<0.0001) and end-exercise PETCO2 (r=0.42, P=0.004). VE/VCO2 correlated with WHO FC, BNP, RAP, MPAP and PASP and 6MWD only with WHO FC, BNP and PASP. Conclusion: SHAPE outperformed 6MWD in comparison with other measures of PAH disease severity.

AB - Introduction: Submaximal exercise testing (SET) assesses functional exercise capacity in pulmonary arterial hypertension (PAH) patients and provides additional physiologic information compared with the 6-min walk test (6MWT). The relative correlations of the 6MWT and SET using SHAPE-HF™ with other markers of PAH severity, particularly echocardiogram (ECHO)-derived mean pulmonary artery pressure (MPAP), have not been investigated. Objectives: (i) Examine the correlation between SHAPE measures with the 6-min walk distance (6MWD), and (ii) Compare SHAPE parameters and the 6MWD to clinical measures of PAH severity. Methods: Fifty-five consecutive group 1 PAH outpatients were evaluated in a single pulmonary hypertension referral center from March 2011 to June 2012. Data collected: World Health Organization (WHO) functional class (FC), brain natriuretic peptide (BNP), ECHO, 6MWD and SHAPE results. Data are reported using mean±standard deviation and Spearman correlation coefficients (r). Results: Nine patients were excluded. Of the 46 remaining patients, 78% were women and the average age was 61±13 years. PAH characteristics: WHO FC III-IV 48%; idiopathic PAH 52%; BNP 198±277pg/mL; 6MWD 399±97m; ECHO right atrial pressure (RAP) 7±4, pulmonary artery systolic pressure (PASP) 63±29 and MPAP 45±17mmHg. SET with SHAPE results: mean partial pressure of end-tidal (PET) CO2 31±6mmHg at end-exercise; ventilatory efficiency (VE/VCO2) 43±16. Significant correlations were found between the 6MWD and SHAPE variables: VE/VCO2 (r=-0.57, P<0.0001) and end-exercise PETCO2 (r=0.42, P=0.004). VE/VCO2 correlated with WHO FC, BNP, RAP, MPAP and PASP and 6MWD only with WHO FC, BNP and PASP. Conclusion: SHAPE outperformed 6MWD in comparison with other measures of PAH disease severity.

KW - Cardiopulmonary exercise test

KW - Echocardiography

KW - Exercise test

KW - Hypertension

KW - Pulmonary

UR - http://www.scopus.com/inward/record.url?scp=84908368630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908368630&partnerID=8YFLogxK

U2 - 10.1111/crj.12085

DO - 10.1111/crj.12085

M3 - Article

C2 - 24308300

AN - SCOPUS:84908368630

VL - 8

SP - 404

EP - 409

JO - Clinical Respiratory Journal

JF - Clinical Respiratory Journal

SN - 1752-6981

IS - 4

ER -